The global Natamycin market was valued at US$ 186 million in 2023 and is anticipated to reach US$ 288.6 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Natamycin Market

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

This report aims to provide a comprehensive presentation of the global market for Natamycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natamycin.

Report Scope

The Natamycin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natamycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Natamycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Natamycin Market Report

Report Metric	Details
Report Name	Natamycin Market
Accounted market size in 2023	US$ 186 million
Forecasted market size in 2030	US$ 288.6 million
CAGR	6.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Glucose-based Lactose-based Sodium chloride-based
Segment by Application	Food Medical Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Natamycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Natamycin Market growing?

Ans: The Natamycin Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Natamycin Market size in 2030?

Ans: The Natamycin Market size in 2030 will be US$ 288.6 million.

What is the market share of major companies in Natamycin Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Natamycin Market report?

Ans: The main players in the Natamycin Market are Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome

What are the Application segmentation covered in the Natamycin Market report?

Ans: The Applications covered in the Natamycin Market report are Food, Medical, Others

What are the Type segmentation covered in the Natamycin Market report?

Ans: The Types covered in the Natamycin Market report are Glucose-based, Lactose-based, Sodium chloride-based

1 Natamycin Market Overview

1.1 Product Overview and Scope of Natamycin

1.2 Natamycin Segment by Type

1.2.1 Global Natamycin Market Value Comparison by Type (2024-2030)

1.2.2 Glucose-based

1.2.3 Lactose-based

1.2.4 Sodium chloride-based

1.3 Natamycin Segment by Application

1.3.1 Global Natamycin Market Value by Application: (2024-2030)

1.3.2 Food

1.3.3 Medical

1.3.4 Others

1.4 Global Natamycin Market Size Estimates and Forecasts

1.4.1 Global Natamycin Revenue 2019-2030

1.4.2 Global Natamycin Sales 2019-2030

1.4.3 Global Natamycin Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Natamycin Market Competition by Manufacturers

2.1 Global Natamycin Sales Market Share by Manufacturers (2019-2024)

2.2 Global Natamycin Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Natamycin Average Price by Manufacturers (2019-2024)

2.4 Global Natamycin Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Natamycin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Natamycin, Product Type & Application

2.7 Natamycin Market Competitive Situation and Trends

2.7.1 Natamycin Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Natamycin Players Market Share by Revenue

2.7.3 Global Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Natamycin Retrospective Market Scenario by Region

3.1 Global Natamycin Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Natamycin Global Natamycin Sales by Region: 2019-2030

3.2.1 Global Natamycin Sales by Region: 2019-2024

3.2.2 Global Natamycin Sales by Region: 2025-2030

3.3 Global Natamycin Global Natamycin Revenue by Region: 2019-2030

3.3.1 Global Natamycin Revenue by Region: 2019-2024

3.3.2 Global Natamycin Revenue by Region: 2025-2030

3.4 North America Natamycin Market Facts & Figures by Country

3.4.1 North America Natamycin Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Natamycin Sales by Country (2019-2030)

3.4.3 North America Natamycin Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Natamycin Market Facts & Figures by Country

3.5.1 Europe Natamycin Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Natamycin Sales by Country (2019-2030)

3.5.3 Europe Natamycin Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Natamycin Market Facts & Figures by Country

3.6.1 Asia Pacific Natamycin Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Natamycin Sales by Country (2019-2030)

3.6.3 Asia Pacific Natamycin Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Natamycin Market Facts & Figures by Country

3.7.1 Latin America Natamycin Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Natamycin Sales by Country (2019-2030)

3.7.3 Latin America Natamycin Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Natamycin Market Facts & Figures by Country

3.8.1 Middle East and Africa Natamycin Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Natamycin Sales by Country (2019-2030)

3.8.3 Middle East and Africa Natamycin Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Natamycin Sales by Type (2019-2030)

4.1.1 Global Natamycin Sales by Type (2019-2024)

4.1.2 Global Natamycin Sales by Type (2025-2030)

4.1.3 Global Natamycin Sales Market Share by Type (2019-2030)

4.2 Global Natamycin Revenue by Type (2019-2030)

4.2.1 Global Natamycin Revenue by Type (2019-2024)

4.2.2 Global Natamycin Revenue by Type (2025-2030)

4.2.3 Global Natamycin Revenue Market Share by Type (2019-2030)

4.3 Global Natamycin Price by Type (2019-2030)

5 Segment by Application

5.1 Global Natamycin Sales by Application (2019-2030)

5.1.1 Global Natamycin Sales by Application (2019-2024)

5.1.2 Global Natamycin Sales by Application (2025-2030)

5.1.3 Global Natamycin Sales Market Share by Application (2019-2030)

5.2 Global Natamycin Revenue by Application (2019-2030)

5.2.1 Global Natamycin Revenue by Application (2019-2024)

5.2.2 Global Natamycin Revenue by Application (2025-2030)

5.2.3 Global Natamycin Revenue Market Share by Application (2019-2030)

5.3 Global Natamycin Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Danisco

6.1.1 Danisco Corporation Information

6.1.2 Danisco Description and Business Overview

6.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Danisco Natamycin Product Portfolio

6.1.5 Danisco Recent Developments/Updates

6.2 DSM

6.2.1 DSM Corporation Information

6.2.2 DSM Description and Business Overview

6.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.2.4 DSM Natamycin Product Portfolio

6.2.5 DSM Recent Developments/Updates

6.3 VGP

6.3.1 VGP Corporation Information

6.3.2 VGP Description and Business Overview

6.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.3.4 VGP Natamycin Product Portfolio

6.3.5 VGP Recent Developments/Updates

6.4 Handary

6.4.1 Handary Corporation Information

6.4.2 Handary Description and Business Overview

6.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Handary Natamycin Product Portfolio

6.4.5 Handary Recent Developments/Updates

6.5 AMTECH BIOTECH

6.5.1 AMTECH BIOTECH Corporation Information

6.5.2 AMTECH BIOTECH Description and Business Overview

6.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AMTECH BIOTECH Natamycin Product Portfolio

6.5.5 AMTECH BIOTECH Recent Developments/Updates

6.6 Silver-Elephant

6.6.1 Silver-Elephant Corporation Information

6.6.2 Silver-Elephant Description and Business Overview

6.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Silver-Elephant Natamycin Product Portfolio

6.6.5 Silver-Elephant Recent Developments/Updates

6.7 Lanzhou Weiri

6.6.1 Lanzhou Weiri Corporation Information

6.6.2 Lanzhou Weiri Description and Business Overview

6.6.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lanzhou Weiri Natamycin Product Portfolio

6.7.5 Lanzhou Weiri Recent Developments/Updates

6.8 Langfang Meihua

6.8.1 Langfang Meihua Corporation Information

6.8.2 Langfang Meihua Description and Business Overview

6.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Langfang Meihua Natamycin Product Portfolio

6.8.5 Langfang Meihua Recent Developments/Updates

6.9 Zhengzhou New Frey

6.9.1 Zhengzhou New Frey Corporation Information

6.9.2 Zhengzhou New Frey Description and Business Overview

6.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Zhengzhou New Frey Natamycin Product Portfolio

6.9.5 Zhengzhou New Frey Recent Developments/Updates

6.10 Chihon

6.10.1 Chihon Corporation Information

6.10.2 Chihon Description and Business Overview

6.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Chihon Natamycin Product Portfolio

6.10.5 Chihon Recent Developments/Updates

6.11 Jiaozuo Joincare

6.11.1 Jiaozuo Joincare Corporation Information

6.11.2 Jiaozuo Joincare Natamycin Description and Business Overview

6.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Jiaozuo Joincare Natamycin Product Portfolio

6.11.5 Jiaozuo Joincare Recent Developments/Updates

6.12 Beijing Oriental Rada

6.12.1 Beijing Oriental Rada Corporation Information

6.12.2 Beijing Oriental Rada Natamycin Description and Business Overview

6.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Beijing Oriental Rada Natamycin Product Portfolio

6.12.5 Beijing Oriental Rada Recent Developments/Updates

6.13 Pucheng Lifecome

6.13.1 Pucheng Lifecome Corporation Information

6.13.2 Pucheng Lifecome Natamycin Description and Business Overview

6.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Pucheng Lifecome Natamycin Product Portfolio

6.13.5 Pucheng Lifecome Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Natamycin Industry Chain Analysis

7.2 Natamycin Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Natamycin Production Mode & Process

7.4 Natamycin Sales and Marketing

7.4.1 Natamycin Sales Channels

7.4.2 Natamycin Distributors

7.5 Natamycin Customers

8 Natamycin Market Dynamics

8.1 Natamycin Industry Trends

8.2 Natamycin Market Drivers

8.3 Natamycin Market Challenges

8.4 Natamycin Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Beijing Oriental Rada

Pucheng Lifecome

List of Tables

Table 1. Global Natamycin Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Natamycin Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Natamycin Market Competitive Situation by Manufacturers in 2023

Table 4. Global Natamycin Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Natamycin Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Natamycin Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Natamycin Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Natamycin Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Natamycin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Natamycin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Natamycin, Product Type & Application

Table 12. Global Key Manufacturers of Natamycin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Natamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Natamycin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Natamycin Sales by Region (2019-2024) & (MT)

Table 18. Global Natamycin Sales Market Share by Region (2019-2024)

Table 19. Global Natamycin Sales by Region (2025-2030) & (MT)

Table 20. Global Natamycin Sales Market Share by Region (2025-2030)

Table 21. Global Natamycin Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Natamycin Revenue Market Share by Region (2019-2024)

Table 23. Global Natamycin Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Natamycin Revenue Market Share by Region (2025-2030)

Table 25. North America Natamycin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Natamycin Sales by Country (2019-2024) & (MT)

Table 27. North America Natamycin Sales by Country (2025-2030) & (MT)

Table 28. North America Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Natamycin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Natamycin Sales by Country (2019-2024) & (MT)

Table 32. Europe Natamycin Sales by Country (2025-2030) & (MT)

Table 33. Europe Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Natamycin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Natamycin Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Natamycin Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Natamycin Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Natamycin Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Natamycin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Natamycin Sales by Country (2019-2024) & (MT)

Table 42. Latin America Natamycin Sales by Country (2025-2030) & (MT)

Table 43. Latin America Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Natamycin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Natamycin Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Natamycin Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Natamycin Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Natamycin Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Natamycin Sales (MT) by Type (2019-2024)

Table 51. Global Natamycin Sales (MT) by Type (2025-2030)

Table 52. Global Natamycin Sales Market Share by Type (2019-2024)

Table 53. Global Natamycin Sales Market Share by Type (2025-2030)

Table 54. Global Natamycin Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Natamycin Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Natamycin Revenue Market Share by Type (2019-2024)

Table 57. Global Natamycin Revenue Market Share by Type (2025-2030)

Table 58. Global Natamycin Price (USD/MT) by Type (2019-2024)

Table 59. Global Natamycin Price (USD/MT) by Type (2025-2030)

Table 60. Global Natamycin Sales (MT) by Application (2019-2024)

Table 61. Global Natamycin Sales (MT) by Application (2025-2030)

Table 62. Global Natamycin Sales Market Share by Application (2019-2024)

Table 63. Global Natamycin Sales Market Share by Application (2025-2030)

Table 64. Global Natamycin Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Natamycin Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Natamycin Revenue Market Share by Application (2019-2024)

Table 67. Global Natamycin Revenue Market Share by Application (2025-2030)

Table 68. Global Natamycin Price (USD/MT) by Application (2019-2024)

Table 69. Global Natamycin Price (USD/MT) by Application (2025-2030)

Table 70. Danisco Corporation Information

Table 71. Danisco Description and Business Overview

Table 72. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. Danisco Natamycin Product

Table 74. Danisco Recent Developments/Updates

Table 75. DSM Corporation Information

Table 76. DSM Description and Business Overview

Table 77. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. DSM Natamycin Product

Table 79. DSM Recent Developments/Updates

Table 80. VGP Corporation Information

Table 81. VGP Description and Business Overview

Table 82. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. VGP Natamycin Product

Table 84. VGP Recent Developments/Updates

Table 85. Handary Corporation Information

Table 86. Handary Description and Business Overview

Table 87. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Handary Natamycin Product

Table 89. Handary Recent Developments/Updates

Table 90. AMTECH BIOTECH Corporation Information

Table 91. AMTECH BIOTECH Description and Business Overview

Table 92. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. AMTECH BIOTECH Natamycin Product

Table 94. AMTECH BIOTECH Recent Developments/Updates

Table 95. Silver-Elephant Corporation Information

Table 96. Silver-Elephant Description and Business Overview

Table 97. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Silver-Elephant Natamycin Product

Table 99. Silver-Elephant Recent Developments/Updates

Table 100. Lanzhou Weiri Corporation Information

Table 101. Lanzhou Weiri Description and Business Overview

Table 102. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Lanzhou Weiri Natamycin Product

Table 104. Lanzhou Weiri Recent Developments/Updates

Table 105. Langfang Meihua Corporation Information

Table 106. Langfang Meihua Description and Business Overview

Table 107. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. Langfang Meihua Natamycin Product

Table 109. Langfang Meihua Recent Developments/Updates

Table 110. Zhengzhou New Frey Corporation Information

Table 111. Zhengzhou New Frey Description and Business Overview

Table 112. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Zhengzhou New Frey Natamycin Product

Table 114. Zhengzhou New Frey Recent Developments/Updates

Table 115. Chihon Corporation Information

Table 116. Chihon Description and Business Overview

Table 117. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. Chihon Natamycin Product

Table 119. Chihon Recent Developments/Updates

Table 120. Jiaozuo Joincare Corporation Information

Table 121. Jiaozuo Joincare Description and Business Overview

Table 122. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 123. Jiaozuo Joincare Natamycin Product

Table 124. Jiaozuo Joincare Recent Developments/Updates

Table 125. Beijing Oriental Rada Corporation Information

Table 126. Beijing Oriental Rada Description and Business Overview

Table 127. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 128. Beijing Oriental Rada Natamycin Product

Table 129. Beijing Oriental Rada Recent Developments/Updates

Table 130. Pucheng Lifecome Corporation Information

Table 131. Pucheng Lifecome Description and Business Overview

Table 132. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 133. Pucheng Lifecome Natamycin Product

Table 134. Pucheng Lifecome Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Natamycin Distributors List

Table 138. Natamycin Customers List

Table 139. Natamycin Market Trends

Table 140. Natamycin Market Drivers

Table 141. Natamycin Market Challenges

Table 142. Natamycin Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Natamycin

Figure 2. Global Natamycin Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Natamycin Market Share by Type in 2023 & 2030

Figure 4. Glucose-based Product Picture

Figure 5. Lactose-based Product Picture

Figure 6. Sodium chloride-based Product Picture

Figure 7. Global Natamycin Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Natamycin Market Share by Application in 2023 & 2030

Figure 9. Food

Figure 10. Medical

Figure 11. Others

Figure 12. Global Natamycin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Natamycin Market Size (2019-2030) & (US$ Million)

Figure 14. Global Natamycin Sales (2019-2030) & (MT)

Figure 15. Global Natamycin Average Price (USD/MT) & (2019-2030)

Figure 16. Natamycin Report Years Considered

Figure 17. Natamycin Sales Share by Manufacturers in 2023

Figure 18. Global Natamycin Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Natamycin Players: Market Share by Revenue in 2023

Figure 20. Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Natamycin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Natamycin Sales Market Share by Country (2019-2030)

Figure 23. North America Natamycin Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Natamycin Sales Market Share by Country (2019-2030)

Figure 27. Europe Natamycin Revenue Market Share by Country (2019-2030)

Figure 28. Germany Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Natamycin Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Natamycin Revenue Market Share by Region (2019-2030)

Figure 35. China Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Natamycin Sales Market Share by Country (2019-2030)

Figure 45. Latin America Natamycin Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Natamycin Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Natamycin Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Natamycin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Natamycin by Type (2019-2030)

Figure 55. Global Revenue Market Share of Natamycin by Type (2019-2030)

Figure 56. Global Natamycin Price (USD/MT) by Type (2019-2030)

Figure 57. Global Sales Market Share of Natamycin by Application (2019-2030)

Figure 58. Global Revenue Market Share of Natamycin by Application (2019-2030)

Figure 59. Global Natamycin Price (USD/MT) by Application (2019-2030)

Figure 60. Natamycin Value Chain

Figure 61. Natamycin Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions